Cargando…

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

Detalles Bibliográficos
Autores principales:	Dizdarevic, S, Tulchinsky, M, McCready, VR, Mihailovic, J, Vinjamuri, S, Buscombe, JR, Lee, ST, Frangos, S, Sathekge, M, Siraj, Q, Choudhury, P, Bom, H, Franceschi, M, Ugrinska, A, Paez, D, Hussain, R, Mailman, J, Luster, M, Virgolini, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476239/ https://www.ncbi.nlm.nih.gov/pubmed/31040741 http://dx.doi.org/10.4103/wjnm.WJNM_117_18

Ejemplares similares

Greetings from the New President of the World Association of Radiopharmaceutical and Molecular Therapy
por: Virgolini, Irene
Publicado: (2018)

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
por: Bolcaen, Julie, et al.
Publicado: (2021)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
por: Barca, Cristina, et al.
Publicado: (2021)

Clinical Studies of Nonpharmacological Methods to Minimize Salivary Gland Damage after Radioiodine Therapy of Differentiated Thyroid Carcinoma: Systematic Review
por: Christou, Andri, et al.
Publicado: (2016)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
por: Funeh, Cyprine Neba, et al.
Publicado: (2023)

Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate
por: Gnanasegaran, Gopinath, et al.
Publicado: (2021)

Correction to: Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate
por: Gnanasegaran, Gopinath, et al.
Publicado: (2022)

International Conference on Radiopharmaceutical Therapy: Speakers Abstracts
Publicado: (2012)

Radiopharmaceutical therapy in cancer: clinical advances and challenges
por: Sgouros, George, et al.
Publicado: (2020)

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
por: Eilsberger, Friederike, et al.
Publicado: (2020)

Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy
por: Park, Hee Jeong, et al.
Publicado: (2017)

Ensuring effective and sustainable radionuclide delivery and its impact on the development of nuclear medicine in the developing world with special reference to Nigeria
por: Orunmuyi, T. Akintunde, et al.
Publicado: (2019)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
por: Pallares, Roger M., et al.
Publicado: (2022)

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)

Long-term carbimazole pretreatment reduces the efficacy of radioiodine therapy
por: Shivaprasad, C., et al.
Publicado: (2015)

Synthesis of Peptide Radiopharmaceuticals for the Therapy and Diagnosis of Tumor Diseases
por: Jamous, Mazen, et al.
Publicado: (2013)

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy
por: Boschi, Alessandra, et al.
Publicado: (2017)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Developments in (177)Lu-based radiopharmaceutical therapy and dosimetry
por: George, Siju C., et al.
Publicado: (2023)

Thyrotoxicosis and radioiodine therapy: Does the dose matter?
por: Collier, Andrew
Publicado: (2012)

Radioiodine therapy and Graves’ disease – Myths and reality
por: Plazinska, Maria Teresa, et al.
Publicado: (2020)

Radioiodine Therapy of Graves' Disease and the Uptake Paradox
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

Personalized radioiodine therapy for thyroid cancer patients with known disease
por: Jhiang, Sissy M, et al.
Publicado: (2021)

To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients
por: Carballo, Marilee, et al.
Publicado: (2012)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014)

Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy
por: Karyampudi, Arun, et al.
Publicado: (2014)

Association between plasma homocysteine and myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia
por: Ankrah, Alfred, et al.
Publicado: (2012)

Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies
por: Abou, Diane S., et al.
Publicado: (2022)

Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
por: Salih, Suliman, et al.
Publicado: (2022)

Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
por: Beauregard, Jean-Mathieu
Publicado: (2022)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
por: Yu, Jingjing, et al.
Publicado: (2023)

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
por: El Fakiri, Mohamed, et al.
Publicado: (2021)

Outcome of Radioiodine Therapy in a West African Population
por: Onimode, Yetunde A., et al.
Publicado: (2016)

The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph Node Mapping in Patients with Breast Cancer and Malignant Melanoma
por: Bennie, George, et al.
Publicado: (2015)

Greetings from the New President of World Association of Radiopharmaceutical and Molecular Therapy
por: Srivastava, Suresh
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5c6lf58l31hcj6trbt38k3l51